Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 5, 2008, Pages 1182-1183

  Werner, Guido ^a   Gfrörer, Sabine ^b,c   Fleige, Carola ^a   Witte, Wolfgang ^a   Klare, Ingo ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b MARIENHOSPITAL STUTTGART   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Glycylcyclines; Omeprazole; Reserpine; TetX

Indexed keywords

ANTIBIOTIC AGENT; DNA 16S; OMEPRAZOLE; PROCHLORPERAZINE; RESERPINE; TIGECYCLINE; VERAPAMIL;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATION; BROTH DILUTION; CASE REPORT; COLON PERFORATION; DEATH; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; FEMUR NECK FRACTURE; GERMANY; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERITONITIS; SEPSIS; STAPHYLOCOCCUS AUREUS; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; GERMANY; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 42149120688     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn065     Document Type: Letter

References (6)

1. Olson MW, Ruzin A, Feyant E et al. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother 2006; 50: 2156-66.
2. Waites KB, Duffy LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother 2006; 50: 3479-84.
3. The European Committee on Antimicrobial Susceptibility Testing (EUCAST), Steering Committee. EUCAST technical note on tigecycline. Clin Microbiol Infect 2006; 12: 1147-9. (see also: Clinical breakpoints for tigecycline - http://www.srga.org/eucastwt/MICTAB/ MICtigecycline.htm; 11 February 2008, date last accessed).
4. Mahamoud A, Chevalier J, Alibert-Franco S et al. Antibiotic efflux pumps in Gram-negative bacteria: The inhibitor response strategy. J Antimicrob Chemother 2007; 59: 1223-9.
5. Moore IF, Hughes DW, Wright GD. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemie 2005; 44: 11829-35.
6. Ruiz-Garbajosa P, Bonten MJ, Robinson DA et al. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 2006; 44: 2220-8.